$RITE Balance Sheet | Understand Stock

$RITE

$0.00 -$0.00 (11.76%) Close

$RITE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q3 FY2014 As of Sep 30, 2014	Q2 FY2014 As of Jun 30, 2014	Q1 FY2012 As of Mar 31, 2012	Q4 FY2011 As of Dec 31, 2011	Q3 FY2011 As of Sep 30, 2011
Cash and cash equivalents
Accounts receivable
Inventory
Prepaid services
Total current assets
Property and equipment:
Property, Plant & Equipment
Furniture and Fixtures
Construction in Progress
Less: Accumulated Depreciation

Less: accumulated depreciation & write downs
Total property and equipment, net
Proven oil and gas properties, full cost method
Less: accumulated depletion
Unproven oil and gas properties
Deferred offering costs
Investments
Mineral royalties
Prepaid services - long-term portion
Website Development, Net
Investment in unconsolidated subsidiary
Assets, Noncurrent
Mineral assets
Total other assets
Total assets
Accounts payable
Royalties due stockholders
Accrued Liabilities, Current
Accrued Payroll
Customer Deposits
Convertible Debt, Including Accrued Interset, Net of Discounts
DueToRelatedPartiesCurrent
Notes Payable, Current
Stockholder loans
Derivative Instruments and Hedges, Liabilities
Other liabilities
Total current liabilities
Long-term liabilities:
Asset retirement obligation
Notes Payable, Noncurrent
Convertible debt
Notes Payable
Total long-term liabilities
Total liabilities
Preferred Stock, Value, Issued
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Series NMC Preferred Stock
Total preferred Stock, Value, Issued

Preferred undesignated; 42,627,000 authorized; 0 issued Common Stock, no par value; 20,000,000,000 authorized 6,249,776,842 issued at 06/30/26; 6,211,776,842 issued at 12/31/25
Additional Paid in Capital, Common Stock
Additional paid-in capital
Accumulated deficit
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Other comprehensive gain/(loss)
Total shareholders’ equity (deficit)
Total liabilities and shareholders’ equity (deficit)

Comments